ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Celecoxib API Market Research Report 2026
Published Date: 2026-04-20
|
Report Code: QYRE-Auto-16L10658
Home | Market Reports
Global and United States Celecoxib API Market Report Forecast 2022 2028
BUY CHAPTERS

Global Celecoxib API Market Research Report 2026

Code: QYRE-Auto-16L10658
Report
2026-04-20
Pages:114
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Aurobindo Pharma
Teva Pharmaceuticals
Jiangsu Hengrui Medicine
ScinoPharm
Hisun Pharmaceutical Nantong
Viatris (MYLAN)
Punjab Chemicals
Jiangxi Synergy
Jiangsu Chiatai Qingjiang

Celecoxib API Market Size

The global Celecoxib API market was valued at US$ 66.86 million in 2025 and is anticipated to reach US$ 92.83 million by 2032, at a CAGR of 4.9% from 2026 to 2032.

Celecoxib API Market

Celecoxib API Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Celecoxib API competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Celecoxib API refers to the active pharmaceutical ingredient (API) of the drug Celecoxib, which is a non-steroidal anti-inflammatory drug (NSAID) used to relieve pain, inflammation, and stiffness caused by conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. The Celecoxib API is the chemical compound responsible for the therapeutic effects of the drug. It is a selective cyclooxygenase-2 (COX-2) inhibitor, which means it works by blocking the production of prostaglandins, which are chemicals produced by the body in response to injury or inflammation. By reducing the production of prostaglandins, Celecoxib can help relieve pain, reduce inflammation, and improve joint mobility. The Celecoxib API is typically manufactured by pharmaceutical companies in accordance with strict quality control standards to ensure its purity, potency, and safety. It is then used to produce finished dosage forms of Celecoxib, such as tablets or capsules, which are prescribed by healthcare professionals to treat various inflammatory conditions.
Global key players of celecoxib API include Pfizer, Jiangxi Synergy, ScinoPharm, Jiangsu Hengrui Medicine, Jiangsu Chiatai Qingjiang, etc. The top five players hold a share over 73%. Asia Pacific is the largest market, has a share about 43%, followed by North America and Europe, with share 28% and 25%, separately.
This report delivers a comprehensive overview of the global Celecoxib API market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Celecoxib API. The Celecoxib API market size, estimates, and forecasts are provided in terms of sales volume (Kg) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Celecoxib API market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Celecoxib API manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Celecoxib API Market Report

Report Metric Details
Report Name Celecoxib API Market
Accounted market size in 2025 US$ 66.86 million
Forecasted market size in 2032 US$ 92.83 million
CAGR 4.9%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Standard grade Celecoxib API
  • Micronized Celecoxib API
by Application
  • Pharmaceutical
  • Laboratory
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, Teva Pharmaceuticals, Viatris(Mylan), ScinoPharm, Jiangxi Synergy, Jiangsu Hengrui Medicine, Jiangsu Chiatai Qingjiang, Hisun Pharmaceutical Nantong, Aurobindo Pharma, Punjab Chemicals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Celecoxib API manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Celecoxib API sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Celecoxib API Market growing?

Ans: The Celecoxib API Market witnessing a CAGR of 4.9% during the forecast period 2026-2032.

What is the Celecoxib API Market size in 2032?

Ans: The Celecoxib API Market size in 2032 will be US$ 92.83 million.

What is the market share of major companies in Celecoxib API Market?

Ans: The top five players hold a share over 73%.

What is the Celecoxib API Market share by region?

Ans: Asia Pacific is the largest market, has a share about 43%, followed by North America and Europe, with share 28% and 25%, separately.

Who are the main players in the Celecoxib API Market report?

Ans: The main players in the Celecoxib API Market are Pfizer, Teva Pharmaceuticals, Viatris(Mylan), ScinoPharm, Jiangxi Synergy, Jiangsu Hengrui Medicine, Jiangsu Chiatai Qingjiang, Hisun Pharmaceutical Nantong, Aurobindo Pharma, Punjab Chemicals

What are the Application segmentation covered in the Celecoxib API Market report?

Ans: The Applications covered in the Celecoxib API Market report are Pharmaceutical, Laboratory

What are the Type segmentation covered in the Celecoxib API Market report?

Ans: The Types covered in the Celecoxib API Market report are Standard grade Celecoxib API, Micronized Celecoxib API

1 Celecoxib API Market Overview
1.1 Product Definition
1.2 Celecoxib API by Type
1.2.1 Global Celecoxib API Market Value by Type: 2025 vs 2032
1.2.2 Standard grade Celecoxib API
1.2.3 Micronized Celecoxib API
1.3 Celecoxib API by Application
1.3.1 Global Celecoxib API Market Value by Application: 2025 vs 2032
1.3.2 Pharmaceutical
1.3.3 Laboratory
1.4 Global Celecoxib API Market Size Estimates and Forecasts
1.4.1 Global Celecoxib API Revenue 2021–2032
1.4.2 Global Celecoxib API Sales 2021–2032
1.4.3 Global Celecoxib API Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Celecoxib API Market Competition by Manufacturers
2.1 Global Celecoxib API Sales Market Share by Manufacturers (2021–2026)
2.2 Global Celecoxib API Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Celecoxib API Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Celecoxib API, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Celecoxib API, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Celecoxib API, Product Types and Applications
2.7 Global Key Manufacturers of Celecoxib API, Date of Entry into the Industry
2.8 Global Celecoxib API Market Competitive Situation and Trends
2.8.1 Global Celecoxib API Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Celecoxib API Players Market Share by Revenue
2.8.3 Global Celecoxib API Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Celecoxib API Market Scenario by Region
3.1 Global Celecoxib API Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Celecoxib API Sales by Region: 2021–2032
3.2.1 Global Celecoxib API Sales by Region: 2021–2026
3.2.2 Global Celecoxib API Sales by Region: 2027–2032
3.3 Global Celecoxib API Revenue by Region: 2021–2032
3.3.1 Global Celecoxib API Revenue by Region: 2021–2026
3.3.2 Global Celecoxib API Revenue by Region: 2027–2032
3.4 North America Celecoxib API Market Facts & Figures by Country
3.4.1 North America Celecoxib API Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Celecoxib API Sales by Country (2021–2032)
3.4.3 North America Celecoxib API Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Celecoxib API Market Facts & Figures by Country
3.5.1 Europe Celecoxib API Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Celecoxib API Sales by Country (2021–2032)
3.5.3 Europe Celecoxib API Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Celecoxib API Market Facts & Figures by Region
3.6.1 Asia Pacific Celecoxib API Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Celecoxib API Sales by Region (2021–2032)
3.6.3 Asia Pacific Celecoxib API Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Celecoxib API Market Facts & Figures by Country
3.7.1 Latin America Celecoxib API Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Celecoxib API Sales by Country (2021–2032)
3.7.3 Latin America Celecoxib API Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Celecoxib API Market Facts & Figures by Country
3.8.1 Middle East and Africa Celecoxib API Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Celecoxib API Sales by Country (2021–2032)
3.8.3 Middle East and Africa Celecoxib API Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Celecoxib API Sales by Type (2021–2032)
4.1.1 Global Celecoxib API Sales by Type (2021–2026)
4.1.2 Global Celecoxib API Sales by Type (2027–2032)
4.1.3 Global Celecoxib API Sales Market Share by Type (2021–2032)
4.2 Global Celecoxib API Revenue by Type (2021–2032)
4.2.1 Global Celecoxib API Revenue by Type (2021–2026)
4.2.2 Global Celecoxib API Revenue by Type (2027–2032)
4.2.3 Global Celecoxib API Revenue Market Share by Type (2021–2032)
4.3 Global Celecoxib API Price by Type (2021–2032)
5 Segment by Application
5.1 Global Celecoxib API Sales by Application (2021–2032)
5.1.1 Global Celecoxib API Sales by Application (2021–2026)
5.1.2 Global Celecoxib API Sales by Application (2027–2032)
5.1.3 Global Celecoxib API Sales Market Share by Application (2021–2032)
5.2 Global Celecoxib API Revenue by Application (2021–2032)
5.2.1 Global Celecoxib API Revenue by Application (2021–2026)
5.2.2 Global Celecoxib API Revenue by Application (2027–2032)
5.2.3 Global Celecoxib API Revenue Market Share by Application (2021–2032)
5.3 Global Celecoxib API Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Celecoxib API Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Pfizer Celecoxib API Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Teva Pharmaceuticals
6.2.1 Teva Pharmaceuticals Company Information
6.2.2 Teva Pharmaceuticals Description and Business Overview
6.2.3 Teva Pharmaceuticals Celecoxib API Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Teva Pharmaceuticals Celecoxib API Product Portfolio
6.2.5 Teva Pharmaceuticals Recent Developments/Updates
6.3 Viatris(Mylan)
6.3.1 Viatris(Mylan) Company Information
6.3.2 Viatris(Mylan) Description and Business Overview
6.3.3 Viatris(Mylan) Celecoxib API Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Viatris(Mylan) Celecoxib API Product Portfolio
6.3.5 Viatris(Mylan) Recent Developments/Updates
6.4 ScinoPharm
6.4.1 ScinoPharm Company Information
6.4.2 ScinoPharm Description and Business Overview
6.4.3 ScinoPharm Celecoxib API Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 ScinoPharm Celecoxib API Product Portfolio
6.4.5 ScinoPharm Recent Developments/Updates
6.5 Jiangxi Synergy
6.5.1 Jiangxi Synergy Company Information
6.5.2 Jiangxi Synergy Description and Business Overview
6.5.3 Jiangxi Synergy Celecoxib API Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Jiangxi Synergy Celecoxib API Product Portfolio
6.5.5 Jiangxi Synergy Recent Developments/Updates
6.6 Jiangsu Hengrui Medicine
6.6.1 Jiangsu Hengrui Medicine Company Information
6.6.2 Jiangsu Hengrui Medicine Description and Business Overview
6.6.3 Jiangsu Hengrui Medicine Celecoxib API Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Jiangsu Hengrui Medicine Celecoxib API Product Portfolio
6.6.5 Jiangsu Hengrui Medicine Recent Developments/Updates
6.7 Jiangsu Chiatai Qingjiang
6.7.1 Jiangsu Chiatai Qingjiang Company Information
6.7.2 Jiangsu Chiatai Qingjiang Description and Business Overview
6.7.3 Jiangsu Chiatai Qingjiang Celecoxib API Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Jiangsu Chiatai Qingjiang Celecoxib API Product Portfolio
6.7.5 Jiangsu Chiatai Qingjiang Recent Developments/Updates
6.8 Hisun Pharmaceutical Nantong
6.8.1 Hisun Pharmaceutical Nantong Company Information
6.8.2 Hisun Pharmaceutical Nantong Description and Business Overview
6.8.3 Hisun Pharmaceutical Nantong Celecoxib API Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Hisun Pharmaceutical Nantong Celecoxib API Product Portfolio
6.8.5 Hisun Pharmaceutical Nantong Recent Developments/Updates
6.9 Aurobindo Pharma
6.9.1 Aurobindo Pharma Company Information
6.9.2 Aurobindo Pharma Description and Business Overview
6.9.3 Aurobindo Pharma Celecoxib API Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Aurobindo Pharma Celecoxib API Product Portfolio
6.9.5 Aurobindo Pharma Recent Developments/Updates
6.10 Punjab Chemicals
6.10.1 Punjab Chemicals Company Information
6.10.2 Punjab Chemicals Description and Business Overview
6.10.3 Punjab Chemicals Celecoxib API Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Punjab Chemicals Celecoxib API Product Portfolio
6.10.5 Punjab Chemicals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Celecoxib API Industry Chain Analysis
7.2 Celecoxib API Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Celecoxib API Production Mode & Process Analysis
7.4 Celecoxib API Sales and Marketing
7.4.1 Celecoxib API Sales Channels
7.4.2 Celecoxib API Distributors
7.5 Celecoxib API Customer Analysis
8 Celecoxib API Market Dynamics
8.1 Celecoxib API Industry Trends
8.2 Celecoxib API Market Drivers
8.3 Celecoxib API Market Challenges
8.4 Celecoxib API Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Aurobindo Pharma
Teva Pharmaceuticals
Jiangsu Hengrui Medicine
ScinoPharm
Hisun Pharmaceutical Nantong
Viatris (MYLAN)
Punjab Chemicals
Jiangxi Synergy
Jiangsu Chiatai Qingjiang
List of Tables
 Table 1. Global Celecoxib API Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Celecoxib API Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Celecoxib API Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Celecoxib API Sales (Kg) of Key Manufacturers (2021–2026)
 Table 5. Global Celecoxib API Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Celecoxib API Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Celecoxib API Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Celecoxib API Average Price (US$/Kg) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Celecoxib API, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Celecoxib API, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Celecoxib API, Product Types and Applications
 Table 12. Global Key Manufacturers of Celecoxib API, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Celecoxib API Companies by Tier (Tier 1, Tier 2, Tier 3), based on Celecoxib API Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Celecoxib API Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Celecoxib API Sales by Region (Kg), 2021–2026
 Table 18. Global Celecoxib API Sales Market Share by Region (2021–2026)
 Table 19. Global Celecoxib API Sales by Region (Kg), 2027–2032
 Table 20. Global Celecoxib API Sales Market Share by Region (2027–2032)
 Table 21. Global Celecoxib API Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Celecoxib API Revenue Market Share by Region (2021–2026)
 Table 23. Global Celecoxib API Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Celecoxib API Revenue Market Share by Region (2027–2032)
 Table 25. North America Celecoxib API Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Celecoxib API Sales by Country (Kg), 2021–2026
 Table 27. North America Celecoxib API Sales by Country (Kg), 2027–2032
 Table 28. North America Celecoxib API Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Celecoxib API Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Celecoxib API Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Celecoxib API Sales by Country (Kg), 2021–2026
 Table 32. Europe Celecoxib API Sales by Country (Kg), 2027–2032
 Table 33. Europe Celecoxib API Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Celecoxib API Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Celecoxib API Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Celecoxib API Sales by Region (Kg), 2021–2026
 Table 37. Asia Pacific Celecoxib API Sales by Region (Kg), 2027–2032
 Table 38. Asia Pacific Celecoxib API Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Celecoxib API Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Celecoxib API Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Celecoxib API Sales by Country (Kg), 2021–2026
 Table 42. Latin America Celecoxib API Sales by Country (Kg), 2027–2032
 Table 43. Latin America Celecoxib API Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Celecoxib API Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Celecoxib API Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Celecoxib API Sales by Country (Kg), 2021–2026
 Table 47. Middle East and Africa Celecoxib API Sales by Country (Kg), 2027–2032
 Table 48. Middle East and Africa Celecoxib API Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Celecoxib API Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Celecoxib API Sales (Kg) by Type (2021–2026)
 Table 51. Global Celecoxib API Sales (Kg) by Type (2027–2032)
 Table 52. Global Celecoxib API Sales Market Share by Type (2021–2026)
 Table 53. Global Celecoxib API Sales Market Share by Type (2027–2032)
 Table 54. Global Celecoxib API Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Celecoxib API Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Celecoxib API Revenue Market Share by Type (2021–2026)
 Table 57. Global Celecoxib API Revenue Market Share by Type (2027–2032)
 Table 58. Global Celecoxib API Price (US$/Kg) by Type (2021–2026)
 Table 59. Global Celecoxib API Price (US$/Kg) by Type (2027–2032)
 Table 60. Global Celecoxib API Sales (Kg) by Application (2021–2026)
 Table 61. Global Celecoxib API Sales (Kg) by Application (2027–2032)
 Table 62. Global Celecoxib API Sales Market Share by Application (2021–2026)
 Table 63. Global Celecoxib API Sales Market Share by Application (2027–2032)
 Table 64. Global Celecoxib API Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Celecoxib API Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Celecoxib API Revenue Market Share by Application (2021–2026)
 Table 67. Global Celecoxib API Revenue Market Share by Application (2027–2032)
 Table 68. Global Celecoxib API Price (US$/Kg) by Application (2021–2026)
 Table 69. Global Celecoxib API Price (US$/Kg) by Application (2027–2032)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Celecoxib API Sales (Kg), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 73. Pfizer Celecoxib API Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. Teva Pharmaceuticals Company Information
 Table 76. Teva Pharmaceuticals Description and Business Overview
 Table 77. Teva Pharmaceuticals Celecoxib API Sales (Kg), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 78. Teva Pharmaceuticals Celecoxib API Product
 Table 79. Teva Pharmaceuticals Recent Developments/Updates
 Table 80. Viatris(Mylan) Company Information
 Table 81. Viatris(Mylan) Description and Business Overview
 Table 82. Viatris(Mylan) Celecoxib API Sales (Kg), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 83. Viatris(Mylan) Celecoxib API Product
 Table 84. Viatris(Mylan) Recent Developments/Updates
 Table 85. ScinoPharm Company Information
 Table 86. ScinoPharm Description and Business Overview
 Table 87. ScinoPharm Celecoxib API Sales (Kg), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 88. ScinoPharm Celecoxib API Product
 Table 89. ScinoPharm Recent Developments/Updates
 Table 90. Jiangxi Synergy Company Information
 Table 91. Jiangxi Synergy Description and Business Overview
 Table 92. Jiangxi Synergy Celecoxib API Sales (Kg), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 93. Jiangxi Synergy Celecoxib API Product
 Table 94. Jiangxi Synergy Recent Developments/Updates
 Table 95. Jiangsu Hengrui Medicine Company Information
 Table 96. Jiangsu Hengrui Medicine Description and Business Overview
 Table 97. Jiangsu Hengrui Medicine Celecoxib API Sales (Kg), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 98. Jiangsu Hengrui Medicine Celecoxib API Product
 Table 99. Jiangsu Hengrui Medicine Recent Developments/Updates
 Table 100. Jiangsu Chiatai Qingjiang Company Information
 Table 101. Jiangsu Chiatai Qingjiang Description and Business Overview
 Table 102. Jiangsu Chiatai Qingjiang Celecoxib API Sales (Kg), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 103. Jiangsu Chiatai Qingjiang Celecoxib API Product
 Table 104. Jiangsu Chiatai Qingjiang Recent Developments/Updates
 Table 105. Hisun Pharmaceutical Nantong Company Information
 Table 106. Hisun Pharmaceutical Nantong Description and Business Overview
 Table 107. Hisun Pharmaceutical Nantong Celecoxib API Sales (Kg), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 108. Hisun Pharmaceutical Nantong Celecoxib API Product
 Table 109. Hisun Pharmaceutical Nantong Recent Developments/Updates
 Table 110. Aurobindo Pharma Company Information
 Table 111. Aurobindo Pharma Description and Business Overview
 Table 112. Aurobindo Pharma Celecoxib API Sales (Kg), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 113. Aurobindo Pharma Celecoxib API Product
 Table 114. Aurobindo Pharma Recent Developments/Updates
 Table 115. Punjab Chemicals Company Information
 Table 116. Punjab Chemicals Description and Business Overview
 Table 117. Punjab Chemicals Celecoxib API Sales (Kg), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 118. Punjab Chemicals Celecoxib API Product
 Table 119. Punjab Chemicals Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Celecoxib API Distributors List
 Table 123. Celecoxib API Customers List
 Table 124. Celecoxib API Market Trends
 Table 125. Celecoxib API Market Drivers
 Table 126. Celecoxib API Market Challenges
 Table 127. Celecoxib API Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Celecoxib API
 Figure 2. Global Celecoxib API Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Celecoxib API Market Share by Type: 2025 & 2032
 Figure 4. Standard grade Celecoxib API Product Picture
 Figure 5. Micronized Celecoxib API Product Picture
 Figure 6. Global Celecoxib API Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Celecoxib API Market Share by Application: 2025 & 2032
 Figure 8. Pharmaceutical
 Figure 9. Laboratory
 Figure 10. Global Celecoxib API Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 11. Global Celecoxib API Market Size (US$ Million), 2021–2032
 Figure 12. Global Celecoxib API Sales (Kg), 2021–2032
 Figure 13. Global Celecoxib API Average Price (US$/Kg), 2021–2032
 Figure 14. Celecoxib API Report Years Considered
 Figure 15. Celecoxib API Sales Share by Manufacturers in 2025
 Figure 16. Global Celecoxib API Revenue Share by Manufacturers in 2025
 Figure 17. Top 5 and Top 10 Global Celecoxib API Players: Market Share by Revenue in Celecoxib API in 2025
 Figure 18. Celecoxib API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 19. Global Celecoxib API Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 20. North America Celecoxib API Sales Market Share by Country (2021–2032)
 Figure 21. North America Celecoxib API Revenue Market Share by Country (2021–2032)
 Figure 22. United States Celecoxib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 23. Canada Celecoxib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Europe Celecoxib API Sales Market Share by Country (2021–2032)
 Figure 25. Europe Celecoxib API Revenue Market Share by Country (2021–2032)
 Figure 26. Germany Celecoxib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. France Celecoxib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. U.K. Celecoxib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. Italy Celecoxib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Russia Celecoxib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Asia Pacific Celecoxib API Sales Market Share by Region (2021–2032)
 Figure 32. Asia Pacific Celecoxib API Revenue Market Share by Region (2021–2032)
 Figure 33. China Celecoxib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Japan Celecoxib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. South Korea Celecoxib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. India Celecoxib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Australia Celecoxib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. China Taiwan Celecoxib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Southeast Asia Celecoxib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Latin America Celecoxib API Sales Market Share by Country (2021–2032)
 Figure 41. Latin America Celecoxib API Revenue Market Share by Country (2021–2032)
 Figure 42. Mexico Celecoxib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Brazil Celecoxib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Argentina Celecoxib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Middle East and Africa Celecoxib API Sales Market Share by Country (2021–2032)
 Figure 46. Middle East and Africa Celecoxib API Revenue Market Share by Country (2021–2032)
 Figure 47. Turkey Celecoxib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Saudi Arabia Celecoxib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. UAE Celecoxib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Global Sales Market Share of Celecoxib API by Type (2021–2032)
 Figure 51. Global Revenue Market Share of Celecoxib API by Type (2021–2032)
 Figure 52. Global Celecoxib API Price (US$/Kg) by Type (2021–2032)
 Figure 53. Global Sales Market Share of Celecoxib API by Application (2021–2032)
 Figure 54. Global Revenue Market Share of Celecoxib API by Application (2021–2032)
 Figure 55. Global Celecoxib API Price (US$/Kg) by Application (2021–2032)
 Figure 56. Celecoxib API Value Chain
 Figure 57. Channels of Distribution (Direct Vs Distribution)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global NSAID API Market Research Report 2024
Global Celecoxib Market Insights Forecast to 2030
Global Celecoxib Capsule Market Insights Forecast to 2030
Global Nonsteroidal Anti inflammatory APIs Market Research Report 2024
Pharma Grade Ibuprofen API Market
Cox 2 Inhibitors Market
Global Ceritinib API Market Research Report 2024
Global Oncology API Market Research Report 2024
Global Cyclooxygenase 2 Inhibitor Market Research Report 2024
Global Cyclooxygenase 2 Inhibitor COVID 19 Market Research Report 2024
Global Corticosteroids API Market Research Report 2025
Global Corticosteroid API Market Research Report 2025
Global Anti inflammatory Agents Market Research Report 2024
Global Meloxicam Drugs Market Research Report 2024
Global Specific COX 2 Inhibitors Market Research Report 2024
Global Piroxicam Market Research Report 2024
Global Cytotoxic Active Pharmaceutical Ingredients API Market Research Report 2025
Global Niche Active Pharmaceutical Ingredients API and Intermediates Market Research Report 2025
Pharmaceutical Grade Celecoxib Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Loxoprofen Sodium Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions